Singapore set to take laboratory deal to Phase II
Singapore’s antitrust enforcer has said it will take an in-depth look into a potential merger between pathology companies Innovative Diagnostics and Quest Laboratories unless they address its concerns.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10